These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP- and cyclic GMP-increasing platelet inhibitors and vasodilators. Grünberg B; Kruse HJ; Negrescu EV; Siess W J Cardiovasc Pharmacol; 1995 Apr; 25(4):545-51. PubMed ID: 7596121 [TBL] [Abstract][Full Text] [Related]
24. Effect of heparin and heparin fractions on platelet aggregation. Salzman EW; Rosenberg RD; Smith MH; Lindon JN; Favreau L J Clin Invest; 1980 Jan; 65(1):64-73. PubMed ID: 6243142 [TBL] [Abstract][Full Text] [Related]
25. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350 [TBL] [Abstract][Full Text] [Related]
26. Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis. Shen YC; Hong CY Br J Pharmacol; 1995 Sep; 116(1):1644-8. PubMed ID: 8564231 [TBL] [Abstract][Full Text] [Related]
27. Calcium-induced platelet aggregation in washed platelets from guinea pigs. Miyamae T; Oshima K; Morikawa T; Hagiwara M Pharmacology; 1995 Sep; 51(3):180-5. PubMed ID: 7501704 [TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets. Matsuoka I; Nakahata N; Nakanishi H Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181 [TBL] [Abstract][Full Text] [Related]
29. Effects of cationic polypeptides on thrombasthenic and afibrinogenemic blood platelets. White JG Am J Pathol; 1972 Sep; 68(3):447-60. PubMed ID: 5054252 [TBL] [Abstract][Full Text] [Related]
30. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2. Miller OV; Gorman RR J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467 [TBL] [Abstract][Full Text] [Related]
31. Antiplatelet effect of demethyldiisoeugenol. Liao CH; Ko FN; Kuo YH; Teng CM Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830 [TBL] [Abstract][Full Text] [Related]
32. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments. Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547 [TBL] [Abstract][Full Text] [Related]
33. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP. Qi R; Ozaki Y; Satoh K; Yang LB; Asazuma N; Yatomi Y; Kume S J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476 [TBL] [Abstract][Full Text] [Related]
34. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Lumley P; White BP; Humphrey PP Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074 [TBL] [Abstract][Full Text] [Related]
35. Effect of serotonin on cyclic nucleotides of human platelets. Agarwal KC; Steiner M Biochem Biophys Res Commun; 1976 Apr; 69(4):962-9. PubMed ID: 179543 [No Abstract] [Full Text] [Related]
36. The mechanism for the inhibitory action of N-(3',4'-dimethoxycinnamoyl)anthranilic acid (tranilast) on the release reaction in platelets. Iwasa Y; Iwasa T; Yoshimura T; Matsui K; Onaya T Eur J Pharmacol; 1988 Jul; 152(1-2):135-9. PubMed ID: 2463171 [TBL] [Abstract][Full Text] [Related]
37. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets. Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979 [TBL] [Abstract][Full Text] [Related]
38. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. Eigenthaler M; Nolte C; Halbrügge M; Walter U Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268 [TBL] [Abstract][Full Text] [Related]
39. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man]. Ardelt W Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100 [TBL] [Abstract][Full Text] [Related]
40. Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding. Laubscher A; Pletscher A; Noll H J Pharmacol Exp Ther; 1981 Feb; 216(2):385-9. PubMed ID: 6109775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]